skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Facial Soft Tissue Augmentation With Bellafill: A Review of 4 Years of Clinical Experience in 212 Patients

Canadian journal of plastic surgery, 2021-05, Vol.29 (2), p.98-102 [Peer Reviewed Journal]

2020 The Author(s) ;2020 The Author(s). ;2020 The Author(s) 2020 Plastic Surgery Journal Corporation ;ISSN: 2292-5503 ;EISSN: 2292-5511 ;EISSN: 1918-1507 ;DOI: 10.1177/2292550320933675 ;PMID: 34026672

Full text available

Citations Cited by
  • Title:
    Facial Soft Tissue Augmentation With Bellafill: A Review of 4 Years of Clinical Experience in 212 Patients
  • Author: Solomon, Philip ; Ng, Chew Lip ; Kerzner, Jaimie ; Rival, Richard
  • Subjects: Acne ; Edema ; Original ; Patient satisfaction ; Scars
  • Is Part Of: Canadian journal of plastic surgery, 2021-05, Vol.29 (2), p.98-102
  • Description: Introduction: Bellafill (Suneva Medical Inc) is a semipermanent injectable soft tissue filler composed of smooth and uniform polymethylmetacrylate (PMMA) microspheres suspended in a bovine collagen gel. It is a third generation PMMA filler, with more uniform shapes and sizes of the PMMA microspheres, which has been purported to decrease the incidence of granuloma formation. Methods: We performed a retrospective review of our clinical experience from 2014 to 2017 with Bellafill as a soft tissue injectable filler in the following clinical scenarios: deep nasolabial folds, depressed facial acne scars, malar volume loss, temporal wasting, tear trough deformity, chin augmentation, angle of jaw augmentation, and lip augmentation. The primary outcome is the rate of adverse events, and the secondary outcome is subjective patient satisfaction. Results: From 2014 to 2017, 842 syringes of Bellafill were administered to 212 patients, for a total of 417 procedures. Of the 417 procedures, 96 (23.0%) were for acne scars, 82 (19.7%) malar volume restorations, 65 (15.6%) nasolabial fold augmentations, 45 (10.8%) chin augmentations, 42 (10.1%) tear trough volume restorations, 28 (6.7%) temple volume restorations, 25 (6.0%) rhinoplasty touch-ups for small areas of nasal depression, 22 (5.3%) lip augmentations, and 12 (2.9%) jaw angle augmentations were performed. A range of 1 to 12 syringes were injected into each patient, over 1 to 3 sessions; 6 cases of adverse events occurred (1.4%). There were 4 cases of solitary nodules in the injection site, 1 case of lower eyelid oedema which persisted for 3 months and 1 case of lower lip oedema which resolved within hours. Patient satisfaction rates ranged from 83.3% for angle of jaw augmentation to 99.0% for improvement of acne scars. Conclusion: Bellafill is a safe and effective option for a semipermanent soft tissue filler, with high patient satisfaction and a good safety profile.
  • Publisher: Los Angeles, CA: SAGE Publications
  • Language: English;French
  • Identifier: ISSN: 2292-5503
    EISSN: 2292-5511
    EISSN: 1918-1507
    DOI: 10.1177/2292550320933675
    PMID: 34026672
  • Source: Open Access: PubMed Central
    Geneva Foundation Free Medical Journals at publisher websites
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait